Cargando…

Synthetic Medicinal Chemistry in Chagas’ Disease: Compounds at The Final Stage of “Hit-To-Lead” Phase

Chagas’ disease, or American trypanosomosiasis, has been the most relevant illness produced by protozoa in Latin America. Synthetic medicinal chemistry efforts have provided an extensive number of chemodiverse hits at the “active-to-hit” stage. However, only a more limited number of these have been...

Descripción completa

Detalles Bibliográficos
Autores principales: Cerecetto, Hugo, González, Mercedes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Diversity Preservation International 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4034012/
https://www.ncbi.nlm.nih.gov/pubmed/27713281
http://dx.doi.org/10.3390/ph3040810
_version_ 1782317916330393600
author Cerecetto, Hugo
González, Mercedes
author_facet Cerecetto, Hugo
González, Mercedes
author_sort Cerecetto, Hugo
collection PubMed
description Chagas’ disease, or American trypanosomosiasis, has been the most relevant illness produced by protozoa in Latin America. Synthetic medicinal chemistry efforts have provided an extensive number of chemodiverse hits at the “active-to-hit” stage. However, only a more limited number of these have been studied in vivo in models of Chagas’ disease. Herein, we survey some of the cantidates able to surpass the “hit-to-lead” stage discussing their limitations or merit to enter in clinical trials in the short term.
format Online
Article
Text
id pubmed-4034012
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Molecular Diversity Preservation International
record_format MEDLINE/PubMed
spelling pubmed-40340122014-05-27 Synthetic Medicinal Chemistry in Chagas’ Disease: Compounds at The Final Stage of “Hit-To-Lead” Phase Cerecetto, Hugo González, Mercedes Pharmaceuticals (Basel) Review Chagas’ disease, or American trypanosomosiasis, has been the most relevant illness produced by protozoa in Latin America. Synthetic medicinal chemistry efforts have provided an extensive number of chemodiverse hits at the “active-to-hit” stage. However, only a more limited number of these have been studied in vivo in models of Chagas’ disease. Herein, we survey some of the cantidates able to surpass the “hit-to-lead” stage discussing their limitations or merit to enter in clinical trials in the short term. Molecular Diversity Preservation International 2010-03-25 /pmc/articles/PMC4034012/ /pubmed/27713281 http://dx.doi.org/10.3390/ph3040810 Text en © 2010 by the authors; licensee Molecular Diversity Preservation International, Basel, Switzerland. http://creativecommons.org/licenses/by/3.0/ This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).
spellingShingle Review
Cerecetto, Hugo
González, Mercedes
Synthetic Medicinal Chemistry in Chagas’ Disease: Compounds at The Final Stage of “Hit-To-Lead” Phase
title Synthetic Medicinal Chemistry in Chagas’ Disease: Compounds at The Final Stage of “Hit-To-Lead” Phase
title_full Synthetic Medicinal Chemistry in Chagas’ Disease: Compounds at The Final Stage of “Hit-To-Lead” Phase
title_fullStr Synthetic Medicinal Chemistry in Chagas’ Disease: Compounds at The Final Stage of “Hit-To-Lead” Phase
title_full_unstemmed Synthetic Medicinal Chemistry in Chagas’ Disease: Compounds at The Final Stage of “Hit-To-Lead” Phase
title_short Synthetic Medicinal Chemistry in Chagas’ Disease: Compounds at The Final Stage of “Hit-To-Lead” Phase
title_sort synthetic medicinal chemistry in chagas’ disease: compounds at the final stage of “hit-to-lead” phase
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4034012/
https://www.ncbi.nlm.nih.gov/pubmed/27713281
http://dx.doi.org/10.3390/ph3040810
work_keys_str_mv AT cerecettohugo syntheticmedicinalchemistryinchagasdiseasecompoundsatthefinalstageofhittoleadphase
AT gonzalezmercedes syntheticmedicinalchemistryinchagasdiseasecompoundsatthefinalstageofhittoleadphase